Position in CDXS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$341,720
+$7,981 QoQ
Shares Held
209,645
+2.4% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,076,997,801 across 270 Biotechnology names. CDXS ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in CDXS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $341,720 | 209,645 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $333,739 | 204,749 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $508,125 | 208,249 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $507,030 | 207,800 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $603,608 | 224,390 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,053,576 | 220,876 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $626,615 | 203,447 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $880,914 | 284,166 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $879,576 | 252,028 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $806,843 | 264,539 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $450,896 | 238,570 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $662,532 | 236,619 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $879,062 | 212,334 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,007,155 | 216,128 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,407,803 | 232,311 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,204,727 | 210,777 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,554,523 | 220,879 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $6,856,290 | 219,261 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,874,015 | 209,545 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $4,011,884 | 177,047 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,901,961 | 214,153 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $2,524,240 | 215,012 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,529,135 | 221,854 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,989,471 | 267,874 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||